CLINICAL_TRIALS
trial_result
· 2017-04-18
Clinical Trial Update: FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer [NA]
Summary
This clinical trial update notes that a study evaluating FDG-PET-CT imaging in metastatic prostate cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Southern California | Conditions: Prostate Cancer | NA | Status: COMPLETED